Managing atrial fibrillation in the CRT patient: Controversy or consensus?

Heart Rhythm

Volumn 9, Issue 8 SUPPL., 2012, Pages

  Upadhyay, Gaurav A ^a   Steinberg, Jonathan S ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Atrial fibrillation; Cardiac resynchronization therapy; Heart failure; Treatment strategies

Indexed keywords

AMIODARONE; DOFETILIDE;

ARTICLE; ATRIOVENTRICULAR JUNCTION ABLATION; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; MORTALITY; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; SHOCK; SINUS RHYTHM; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; HEART FAILURE; HUMANS; INCIDENCE; PULMONARY VEINS; RISK ASSESSMENT; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84864279210     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.04.030     Document Type: Article

References (56)

1. J.S. Steinberg Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation J Am Coll Cardiol 48 2006 744 746
2. D.M. Lloyd-Jones, M.G. Larson, E.P. Leip Lifetime risk for developing congestive heart failure: The Framingham Heart Study Circulation 106 2002 3068 3072
3. V.L. Roger, A.S. Go, D.M. Lloyd-Jones Heart disease and stroke statistics - 2011 update: A report from the American Heart Association Circulation 123 2011 e18 e209
4. D. Lloyd-Jones, R.J. Adams, T.M. Brown Heart disease and stroke statistics - 2010 update: A report from the American Heart Association Circulation 121 2010 e46 e215
5. D.M. Lloyd-Jones, T.J. Wang, E.P. Leip Lifetime risk for development of atrial fibrillation: The Framingham Heart Study Circulation 110 2004 1042 1046
6. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
7. W.H. Maisel, L.W. Stevenson Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy Am J Cardiol 91 2003 2D 8D
8. D.J. Bradley, E.A. Bradley, K.L. Baughman Cardiac resynchronization and death from progressive heart failure: s meta-analysis of randomized controlled trials Jama 289 2003 730 740
9. F.A. McAlister, J. Ezekowitz, N. Hooton Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review Jama 297 2007 2502 2514
10. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) Circulation 117 2008 e350 e408
11. G.A. Upadhyay, N.K. Choudhry, A. Auricchio, J. Ruskin, J.P. Singh Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies J Am Coll Cardiol 52 2008 1239 1246
12. S.B. Wilton, A.A. Leung, W.A. Ghali, P. Faris, D.V. Exner Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis Heart Rhythm 8 2011 1088 1094
13. J.G. Cleland, J.C. Daubert, E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
14. U.C. Hoppe, J.M. Casares, H. Eiskjaer Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure Circulation 114 2006 18 25
15. L.A. Saxon Does cardiac resynchronization therapy reduce the incidence of atrial fibrillation, and does atrial fibrillation compromise the cardiac resynchronization therapy effect? Heart Rhythm 4 2007 S31 S33
16. E. Marijon, S. Jacob, E. Mouton Frequency of atrial tachyarrhythmias in patients treated by cardiac resynchronization (from the prospective, multicenter Mona Lisa study) Am J Cardiol 106 2010 688 693
17. C. Leclercq, L. Padeletti, R. Cihak Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics Europace 12 2010 71 77
18. J.C. Caldwell, H. Contractor, S. Petkar Atrial fibrillation is under-recognized in chronic heart failure: Insights from a heart failure cohort treated with cardiac resynchronization therapy Europace 11 2009 1295 1300
19. C.J. Borleffs, C. Ypenburg, R.J. van Bommel Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy Heart Rhythm 6 2009 305 310
20. A. Puglisi, M. Gasparini, M. Lunati Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients J Cardiovasc Electrophysiol 19 2008 693 701
21. G. Boriani, M. Gasparini, M. Landolina Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy EurJ Heart Fail 13 2011 868 876
22. B. Hugl, H.J. Bruns, C. Unterberg-Buchwald Atrial fibrillation burden during the post-implant period after CRT using device-based diagnostics J Cardiovasc Electrophysiol 17 2006 813 817
23. N. Lellouche, C. De Diego, M. Vaseghi Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation Pacing Clin Electrophysiol 30 2007 1363 1368
24. M. Gasparini, J.S. Steinberg, A. Arshad Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study Eur Heart J 31 2010 976 983
25. M. Gasparini, A. Auricchio, F. Regoli Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation J Am Coll Cardiol 48 2006 734 743
26. G.S. Kamath, D. Cotiga, J.N. Koneru The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy J Am Coll Cardiol 53 2009 1050 1055
27. B.A. Koplan, A.J. Kaplan, S. Weiner, P.W. Jones, M. Seth, S.A. Christman Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol 53 2009 355 360
28. D.L. Hayes, J.P. Boehmer, J.D. Day Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival Heart Rhythm 8 2011 1469 1475
29. M.O. Sweeney, M.S. Wathen, K. Volosin Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT Reduces Shock Therapies (PainFREE RX II) trial Circulation 111 2005 2898 2905
30. G.C. Gronefeld, O. Mauss, Y.G. Li, T. Klingenheben, S.H. Hohnloser Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study J Cardiovasc Electrophysiol 11 2000 1208 1214
31. M. Rienstra, M.D. Smit, W. Nieuwland Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator Am Heart J 153 2007 120 126
32. J.E. Poole, G.W. Johnson, A.S. Hellkamp Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
33. J.P. Daubert, W. Zareba, D.S. Cannom Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact J Am Coll Cardiol 51 2008 1357 1365
34. J.B. van Rees, C.J. Borleffs, M.K. de Bie Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality J Am Coll Cardiol 57 2011 556 562
35. D.G. Wyse, A.L. Waldo, J.P. DiMarco A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
36. S.D. Corley, A.E. Epstein, J.P. DiMarco Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Circulation 109 2004 1509 1513
37. M. Guglin, R. Chen, A.B. Curtis Sinus rhythm is associated with fewer heart failure symptoms: Insights from the AFFIRM trial Heart Rhythm 7 2010 596 601
38. P.C. Deedwania, B.N. Singh, K. Ellenbogen, S. Fisher, R. Fletcher, S.N. Singh Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Circulation 98 1998 2574 2579
39. O.D. Pedersen, H. Bagger, N. Keller, B. Marchant, L. Kober, C. Torp-Pedersen Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) substudy Circulation 104 2001 292 296
40. V.E. Hagens, H.J. Crijns, D.J. Van Veldhuisen Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the Rate Control versus Electrical Cardioversion (RACE) study Am Heart J 149 2005 1106 1111
41. D. Roy, M. Talajic, S. Nattel Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677
42. M. Gasparini, F. Regoli, P. Galimberti, C. Ceriotti, A. Cappelleri Cardiac resynchronization therapy in heart failure patients with atrial fibrillation Europace 11 Suppl 5 2009 v82 v86
43. I.C. Van Gelder, H.F. Groenveld, H.J. Crijns Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 2010 1363 1373
44. P.P. Delnoy, J.P. Ottervanger, H.O. Luttikhuis Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure Am J Cardiol 99 2007 1252 1257
45. C. Linde, C. Leclercq, S. Rex Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) study J Am Coll Cardiol 40 2002 111 118
46. M. Gasparini, A. Auricchio, M. Metra Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation Eur Heart J 29 2008 1644 1652
47. A.M. Ferreira, P. Adragao, D.M. Cavaco Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation Europace 10 2008 809 815
48. K. Dong, W.K. Shen, B.D. Powell Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy Heart Rhythm 7 2010 1240 1245
49. K. Khadjooi, P.W. Foley, S. Chalil Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation Heart 94 2008 879 883
50. F. Schutte, G. Ludorff, R. Grove, W. Kranig, J. Thale Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation Cardiology 16 2009 246 249
51. I. Nault, S. Miyazaki, A. Forclaz Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation Eur Heart J 31 2010 1046 1054
52. J.P. Piccini, R.D. Lopes, M.H. Kong, V. Hasselblad, K. Jackson, S.M. Al-Khatib Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials Circ Antiarrhythm Electrophysiol 2 2009 626 633
53. R.M. Hayward, G.A. Upadhyay, T. Mela Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: a meta-analysis Heart Rhythm 8 2011 994 1000
54. A. Khan, S. Mittal, G.S. Kamath, N.V. Garikipati, D. Marrero, J.S. Steinberg Pulmonary vein isolation alone in patients with persistent atrial fibrillation: an ablation strategy facilitated by antiarrhythmic drug induced reverse remodeling J Cardiovasc Electrophysiol 22 2011 142 148
55. N.V. Garikipati, A. Avula, P. Verma, S. Mittal, J. Steinberg Pulmonary vein isolation in patients with left ventricular dysfunction: a meta-analysis J Am Coll Cardiol 57 2011 E16
56. M.N. Khan, P. Jais, J. Cummings Pulmonary-vein isolation for atrial fibrillation in patients with heart failure N Engl J Med 359 2008 1778 1785